Machine that aided moon landing to go to Scots museum as anniversary approaches
With the anniversary of the moon landing later this month, the Facit Model LX calculator, used by Scots scientist Archie Roy (1924-2012) during the mission, will be donated to National Museums Scotland.
He was asked by Nasa to be a consultant on trajectory calculations for the Apollo 11 mission, which led to the first humans landing on the moon on July 20 1969.
Prof Roy is thought to have acquired the mechanical calculator to enable him to complete his PhD, which he was awarded in 1954, and continued to use it through the 1960s until it was gradually superseded by electronic computers.
The Facit Model LX calculator was manufactured in Sweden from 1938 to 1954.
The one used by Prof Roy has been added to National Museums Scotland's science and technology collections, where it will be used to make connections with other material relating to space, astronomy and calculation, including a prototype camera designed for use on the moon, and an analogue calculator for the solution of Kepler's equation.
After Prof Roy's retirement in September 1989, his friend and colleague, the Astronomer Royal for Scotland, John Brown, recognised the calculator's significance to the history of science and held it for safekeeping before his widow Margaret donated it to National Museums Scotland.
Dr Tacye Philipson, senior curator of science at National Museums Scotland, said: 'This is a wonderful addition to the National Collection for many reasons. It is a visibly well-used piece of kit, reflecting Professor Archie Roy's long and productive career.
'Moreover, when we think of the array of computational power at our fingertips today with our phones and laptops, it is evocative to look at this completely analogue machine and think that it was instrumental in one of the most extraordinary technological achievements in human history, one unsurpassed and even unrepeated in over 50 years.
'Professor Roy's calculator gives us a tangible link to Scotland's part in that achievement.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
11 minutes ago
- The Guardian
Is it true that … cracking your knuckles causes arthritis?
'This is a common question I get asked over the dinner table,' says Kimme Hyrich, a rheumatologist and professor of epidemiology at the University of Manchester. And it's no wonder – as many as 54% of us are habitual knuckle crackers, regularly making those distinctive popping noises as we manipulate the joints. 'The knuckle joint is a very tight space and there's a little bit of fluid in it. When people crack their knuckles, they very temporarily enlarge the space,' says Hyrich. 'The pressure drops and gas that's dissolved in that fluid forms bubbles – and it's the bursting of those bubbles that causes the sound.' The type of arthritis people tend to worry about is osteoarthritis – the most common form. It's a painful condition that causes swelling and stiffness in the joints, and becomes more common as we age. 'We don't fully understand the cause,' Hyrich says, 'but genetics play a large role. Joint trauma is also a risk factor.' It's probably this association with injury that fuels concerns about knuckle-cracking. 'People are likely worried they're damaging the joint,' she says. But is there any actual harm? According to Hyrich, the evidence says no. 'Researchers have looked at people with and without arthritis and asked whether they cracked their knuckles – there's been no difference. Others have compared people who do and don't crack their knuckles using X-rays – again, no difference.' Perhaps the most famous example is a US physician who, in an effort to prove his mother wrong, cracked the knuckles on just one hand every day for over 60 years. When he finally had both hands assessed, there were no signs of arthritis in either. So what kinds of trauma do increase your risk of osteoarthritis? 'Sporting injuries,' Hyrich says, 'such as breaking a bone near your joint, or tearing ligaments.' People who already have another kind of arthritis, such as the autoimmune condition rheumatoid arthritis, are also more prone to osteoarthritis. Her best advice for avoiding it? 'Maintain a healthy lifestyle, stay active, and keep to a healthy weight.'
The Independent
40 minutes ago
- The Independent
Groundbreaking cancer trial to recruit patients within the NHS
A new immunotherapy drug trial for glioblastoma, the deadliest form of brain cancer, is now recruiting patients in the NHS. The trial follows a previous study where patient Ben Trotman's tumour vanished, and he has shown no signs of the disease for over two years, a rare outcome for glioblastoma. The NHS study will enrol 16 patients over 18 months, who will receive the immunotherapy drug ipilimumab before standard treatment. The trial was established in memory of Baroness Margaret McDonagh, who died from the disease, and was funded by over £1 million raised by her sister, Dame Siobhain McDonagh MP. Led by Consultant Medical Oncologist Dr Paul Mulholland, the trial aims to build on previous findings and offers significant hope for patients with this aggressive cancer. Dad's aggressive brain cancer vanishes after taking new drug
The Guardian
an hour ago
- The Guardian
Burkitt review – fascinating film intertwines lives of patient and trailblazing surgeon
In Éanna Mac Cana's probing documentary, two lives are entwined with fascinating results. The seeds for the film were first planted when Mac Cana was diagnosed with Burkitt's lymphoma, a rare and aggressive cancer; his diaristic videos capture the loneliness of his treatment, spent within the cold, yellow walls of hospital rooms. Through the lens of his digital camera, he occasionally takes in the distant, blurry sight of tower blocks, or his mother cycling to the clinic. The world outside appears impenetrable; all the while, the film reaches beyond what the eyes can see. Then, turning to the past, Mac Cana juxtaposes his lived experience of illness with the life story of Denis Burkitt, the trailblazing Irish surgeon after whom Mac Cana's condition was named. From archival materials as well as interviews with experts and Burkitt's family, Mac Cana charts the trajectory of the scientist's career in Africa. Cartography is, in fact, central to Burkitt's research into the disease: like his father, a keen amateur ornithologist who documented bird migration, Burkitt traced the geographical distribution of the then-unknown paediatric cancer in the continent. Mac Cana's stylistic choices become another form of mapping, with Burkitt's charts and drawings occasionally laid over the film-maker's own images. The effect resembles a visual tree branch, one that connects the past and the present, the scientific and the personal. Burkitt's colossal archive of photographs makes for another link, even if the scientist's colonial gaze gets not much more than a mention. Still, this is far from a work of hagiography: by highlighting some of the more melancholic chapters of Burkitt's private life, Mac Cana lends a human element to the legacy of a pioneer. Burkitt is on True Story from 25 July.
